A Oneindia Venture

Get Updates

Get notified about market trends, financial advice, and investment tips!

सेंसेक्स 73,134.32 +1.65% ↑ निफ्टी 22,701.35 +1.66% ↑ सोना ₹ 14,035/gm चांदी ₹ 2,55,000/kg पेट्रोल ₹ 94.77 डीज़ल ₹ 87.67 एलपीजी ₹ 913.00 कच्चा तेल $ 101.66 USD ₹ 93.42

Invicta Diagnostic Ltd. IPO

Q: What is the size of Invicta Diagnostic Ltd. IPO?

The size of the Invicta Diagnostic Ltd. IPO is &#8377;28.12 Cr.

Q: What is the price range of Invicta Diagnostic Ltd. IPO?

The price range of Invicta Diagnostic Ltd. IPO is at &#8377;80 to &#8377;85 per share.

Q: What is the minimum investment and lot size required for the Invicta Diagnostic Ltd. IPO?

The minimum investment required is &#8377;1,36,000 and minimum lot size is 1600 shares.

Min Investment

₹ 1,36,000 / 1600 shares

Price Range

₹80 - ₹ 85

Bidding Dates

1 Dec '25 - 3 Dec '25

Total Issue Value

28.12 Cr

Lot Size

1,600

Total Issue Size

28.12 Cr

Listing At

NSE SME

Subscription

4.07 times

NSE Price

79.30 (-6.71%)

IPO Timeline

1 Dec 2025

Bidding Starts
3 Dec 2025

Bidding Ends
4 Dec 2025

Allotment Finalization
8 Dec 2025

Listing

About Invicta Diagnostic Ltd.

We are a diagnostic chain in Mumbai Metropolitan Region (“MMR”) offering radiology and pathology solutions. We offer radiology and pathology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers under the brand name “PC ... Read more

Parent organisation

Founded

Invicta Diagnostic Ltd.

2023

Invicta Diagnostic Ltd. IPO Reservation

Investors Category	Shares Offered
Anchor Investors	9,92,640 (30%)
Non Institutional Investors	4,96,320 (15%)
Qualified Institutional Buyers (QIBs)	6,61,760 (20%)
Retail Individual Investors (RIIs)	11,58,080 (35%)

Invicta Diagnostic Ltd. Financial Information

Year End	Revenue	PAT	Reserves & Surplus
31 Mar 2025	17.73 Cr	5.38 Cr	6.39 Cr
31 Mar 2024	4.92 Cr	2.20 Cr	7.42 Cr
31 Mar 2023	6.85 Cr	23.66 Lakh	0

Invicta Diagnostic Ltd. Background

Major Events And Milestones

2021

Incorporation of Erstwhile LLP
Setting up of 1st fully integrated Diagnostic Centre in Thane having the entire gamut of services under its umbrella including PET CT scans, CT scans, MRI Scans, Sonography, X-Ray and Pathology
2023

Conversion of Erstwhile LLP into a private limited company “Invicta Diagnostic Private Limited” pursuant to the provisions of Chapter XXI of the Companies Act,
2013

Acquisition of majority shareholding in “PCD Diagnostics LLP” for a full-fledged diagnostic centre in Marol, Andheri East, forming it our subsidiary
Acquisition of majority shareholding in “Primacare Healthcare LLP” for a full-fledged diagnostic centre in Byculla, forming it our subsidiary
Acquisition of majority shareholding in “Pratham MRI and CT Scan Centre” for a full-fledged diagnostic centre in Bhayandar, forming it our subsidiary
2024

Acquisition of a diagnostic centre in Sewri from PCD Medical LLP
Acquisition of a diagnostic centre in Parel from Primacare Diagnostic LLP
Acquisition of a centralised laboratory in Parel from Porteus Path Lab LLP
Formation of our subsidiary “Invicta Medical LLP” for setting up of diagnostic centre in Kalwa,Thane
Conversion from Private Limited to Public Limited Company
2025

Acquisition of “Porteus Medical LLP” (Formerly known as “Porteus Porteus Path Lab LLP”) for forming it our subsidiary
Acquisition of “Primacare Diagnostic LLP” for setting up of diagnostic centre in Dadar, Mumbai, forming it our subsidiary
Acquisition of “MSCRIBEIT Infotech LLP” (Formerly Knowns as “PCD Medical LLP”) forming it our Associate

Invicta Diagnostic Ltd. Object of Issues

1. Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra
2. General Corporate purposes

Invicta Diagnostic Ltd. IPO Listing Details

Listing Date

8 Dec 2025

NSE Symbol

INVICTA

ISIN

INE0XJ501010

Final Issue Price

₹ 85

Invicta Diagnostic Ltd. Listing Day Trading Information

Pricing Details	BSE	NSE
Issue Price	-	₹ 85.00
Open	-	₹ 100.00
Low	-	₹ 95.00
High	-	₹ 105.00
Last Trade	-	₹ 96.70

Invicta Diagnostic Ltd. Company Promoters

1. Dr. Ketan Jayantilal Jain
2. Dr. Sanket Vinod Jain
3. Rohit Prakash Srivastava
4. Badal Kailash Naredi
5. Jayesh Prakash Jain

Industry Overview

Diagnostic services identify health conditions, ensuring diagnosis, treatment planning, and recovery. Catering to B2B (hospitals, clinics) and B2C (direct customers), these services are segmented into Pathology and Radiology. In India, the Radiology industry grew at a CAGR of 11.5% from 2020 to ... Read more

Invicta Diagnostic Ltd. Contact Details

Address: 1 GF, Plot 217, Ambavat Bhavan, N.M Joshi Marg, Delisle Road, Mumbai Maharashtra - 400013
Phone no:49710036

Email: [email protected]

49710036

Visit Website

Invicta Diagnostic Ltd. IPO Registrar

Bigshare Services Pvt. Ltd.

S6-2, 6th Floor, Pinnacle Business Park, Mahakali Caves Road, Next to Ahura Centre, Andheri East, Mumbai Maharashtra - 400093

62638200

Invicta Diagnostic Ltd. IPO Lead Manager(s)

Socradamus Capital Pvt. Ltd.

Gala No. 303, Cama Industrial Estate, Sun Mill Compound, Delisle Road, Lower Parel (West), Mumbai Maharashtra - 400013

49614235

FAQs

When does Invicta Diagnostic Ltd. IPO opens and closes?

Invicta Diagnostic Ltd. IPO opens from 1st December to 3rd December 2025.

What is the size of Invicta Diagnostic Ltd. IPO?

The size of the Invicta Diagnostic Ltd. IPO is ₹28.12 Cr.

What is the price range of Invicta Diagnostic Ltd. IPO?

The price range of Invicta Diagnostic Ltd. IPO is at ₹80 to ₹85 per share.

What is the minimum investment and lot size required for the Invicta Diagnostic Ltd. IPO?

The minimum investment required is ₹1,36,000 and minimum lot size is 1600 shares.

When is Invicta Diagnostic Ltd. IPO listing date?

The Invicta Diagnostic Ltd. IPO will be listed on 8th December 2025.

What is the objective of Invicta Diagnostic Ltd. IPO?

1. Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra
2. General Corporate purposes

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article